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Background: In the absence of overt clinical signs of Johne’s Disease (JD), laboratory based tests have largely been
limited to organism detection via faecal culture or PCR and serological tests for antibody reactivity. In this study we
describe the application of quantitative faecal PCR for the detection of Mycobacterium avium subsp. paratuberculosis
(MAP) in New Zealand farmed deer to quantify the bacterial load in cervine faecal samples as an adjunct to an
existing serodiagnostic test (Paralisa™) tailored for JD diagnosis in deer. As ELISA has potential as a cheap, high
throughput screening test for JD, an attempt was made to assess the sensitivity, specificity and positive/negative
predictive (PPV/NPV) values of Paralisa™ for estimating levels of faecal shedding of MAP as a basis for JD
management in deer.
Results: Correlations were made between diagnostic tests (ELISA, qPCR, culture and histopathology) to establish
the precision and predictive values of individual tests. The findings from this study suggest there is strong
correlation between bacterial shedding, as determined by faecal qPCR, with both culture (r = 0.9325) and
histopathological lesion severity scoring (r = 0.7345). Correlation between faecal shedding and ELISA reactivity in
deer was weaker with values of r = 0.4325 and r = 0.4006 for Johnin and Protoplasmic antigens, respectively. At an
ELISA Unit (EU) cutoff of >50 (Johnin antigen) the PPV of Paralisa™ for significant faecal shedding in deer
(>104 organisms/g) was moderate (0.55) while the NPV was higher (0.89). At an EU cutoff of ≥150, the PPV for
shedding >105 organisms/g rose to 0.88, with a corresponding NPV of 0.85.
Conclusions: The evidence available from this study suggests that Paralisa™ used at a cutoff of 50EU could be used
to screen deer herds for MAP infection with sequential qPCR testing used to cull all Paralisa™ positive animals that
exhibit significant MAP faecal shedding.
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New Zealand (NZ) is unique in that it has a population of
more than 1.2 million farmed European red deer (Cervus
elaphus), a farming practice not commonly employed
internationally. Johne’s Disease (JD), caused by infection
with Mycobacterium avium subsp. paratuberculosis (MAP)
in deer presents as a unique syndrome and is increasingly
recognised as a production limiting disease of concern to
the NZ deer farming industry. In deer, JD manifests as an
acute infection with progression from infection through to
clinical disease or death occurring more rapidly than in
cattle or sheep and with some particularly susceptible ani-
mals dying from the disease as early as eight months of age
[1]. Consequently there is a need for accurate diagnostic
tests for MAP infection in farmed deer, where JD may re-
sult in serious losses [2].
Deer mount a vigorous immune response to MAP in-
fection characterised by high titres of antibody [3] and
are capable of shedding large numbers of MAP organ-
isms into the environment as the disease progresses
from the paucibacillary to multibacillary state [4]. In
contrast to cattle and sheep, young deer (<1 year of age)
appear to be especially susceptible to challenge with the
bovine strain of MAP [5] although ovine strain MAP has
also been implicated in cervine JD on occasion [6].
Nonetheless, most farmed deer herds that are affected
by MAP do not suffer from overt clinical losses due to
JD and good management practices appear to keep dis-
ease problems at a level that is acceptable within normal
farming production systems in NZ. The motivation to
introduce diagnostic methods that are appropriate and
effective places extreme demands on diagnostic plat-
forms used to support control of MAP in domesticated
ruminants, for a disease that is only rarely obvious as a
health hazard.
As is the case for all chronic, mycobacterial diseases in
humans and animals, the development and validation of
sensitive and specific diagnostic methods to diagnose
infection and disease is particularly challenging. Per-
ceived imprecision of available tests reflects the biology
of mycobacterial infection and the chronology of the re-
sultant immune responses triggered within the host,
coupled with the existence of closely related and anti-
genically very similar mycobacterial species ubiquitous
within the environment. These factors dictate that, how-
ever urgently they may be needed, the development of
tests that more accurately and cost effectively diagnose
MAP infection or JD in domestic animals is difficult. As
no existing single test ticks every box in terms of
sensitivity, specificity, turnaround and cost-effectiveness,
combinations of different tests are necessary to achieve
optimal diagnosis. Commonly utilised ante-mortem diag-
nostic tests for JD include immunodiagnostic tests for
serum antibody by ELISA or organism based tests todetect the presence of the bacterium, such as faecal cul-
ture or PCR. The specificity of serological diagnostic
tests may be compromised by common antigens shared
by MAP, M. bovis and other saprophytic environmental
mycobacteria that evoke an immune response in non-
diseased animals. The sensitivity of serodiagnostic tests,
particularly for subclinically infected animals in the early
stages of JD, is also influenced by the dynamics of anti-
body production and the point at which a sample is
assayed due to the predominantly cellular immune re-
sponses found in the early stages of disease, limiting the
predictive value of the test [7]. Performance of commer-
cially available serodiagnostic test kits is further chal-
lenged when considering host species other than the
target species for which they were developed; commer-
cial ELISA kits may have limited or no capacity to detect
antibodies from different host species such as deer [8].
While faecal culture on Herrold’s egg yolk (HEY) medium
has remained the definitive test for MAP infection this re-
quires prolonged incubation periods of up to sixteen weeks
and may be compromised by overgrowth by contaminating
gut microflora [9-13]. Radiometric tests (BACTEC™) have
been developed as a substitute for traditional faecal culture
tests and have been widely adopted as they speed up the
time to detect mycobacterial growth [14].
Diagnostic tests available to deer farmers in NZ have
included conventional pooled and individual faecal cul-
ture on solid and BACTEC™ medium as well as indirect
ELISA and agar gel immunodiffusion, each with associated
strengths and weaknesses. In addition, there is available an
IgG1 ELISA (Paralisa
™) test developed specifically for the
diagnosis of MAP infection in deer through the detection
of antibody to denatured Johnin (PPD-J) and native Proto-
plasmic (PPA) antigens; the antibody responses to both
test antigens are considered in parallel to arrive at a final
result [3,15]. Initial studies in deer [15,16] have suggested
that subclinically affected deer produce higher levels of
seroreactivity (IgG1) than has been shown previously in
cattle [17] or sheep [18]. ELISA techniques such as the
Paralisa™ lend themselves well to automation using la-
boratory robotics thereby reducing labour costs and turn-
around time; this facet is one of the great strengths of
ELISA as a screening technique as it allows whole herds or
sub-populations of animals to be economically screened,
quickly informing management decisions.
Because JD presents as an enteropathy and the intes-
tine is the major site of colonisation of the causative
agent, faecal samples are an obvious ante-mortem source
material with which to attempt to diagnose MAP infec-
tion and faeces are considered to be one of the most im-
portant materials for diagnosis of JD in the live animal
because it is possible to identify subclinical and clinical
animals relative to the level of shedding of MAP orga-
nisms [19]. In deer, it has been reported that animals
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106 colony forming units of bacteria per gram of faeces
[20] and that an infective dose can be as low as 103 or-
ganisms [21]. Internationally, attention has increasingly
turned towards rapid, nucleic acid amplification based
approaches for the confirmation and quantification of
MAP bacilli in faecal samples [11,12,22-28]. DNA ampli-
fication (PCR) based tests are attractive due to their low
cost and high speed and have become established as a
mainstream diagnostic methodology for a variety of
pathogenic organisms [29]. The inclusion of fluorescent
reporter dyes has allowed PCR to be used quantitatively
to determine the bacterial load in individual samples
allowing distinctions to be made between high, medium
and low or non-shedders; this aspect of the technique
could be an invaluable JD management tool for selective
culling of infectious/shedding animals, to facilitate con-
trol in infected herds and accredit low-risk replacement
animals for introduction into herds. A recent compara-
tive study of qPCR [30], solid and liquid culture and
ELISA for detection of MAP in cattle based on 143 sam-
ples concluded using Bayesian methodology (independ-
ent of a gold standard) that test sensitivity for culture
methods and qPCR, as well as test accuracy, are compar-
able. Sensitivity and specificity of qPCR in this case were
reported to be 0.60 and 0.97, respectively; accuracy of
qPCR (0.90) was comparable to both solid (0.91) and li-
quid (0.93) culture leading the authors to conclude
that qPCR has considerable potential to quantify MAP
in faecal samples.
While there are numerous reports describing quantita-
tion of MAP shedding in cattle and sheep, there have
been no reports describing quantitation of MAP shedding
in cervine faeces by PCR or any observed correlation be-
tween faecal shedding and other diagnostic parameters in
deer. The current study attempts to compare diagnostic
precision of ELISA, qPCR, culture and histopathological
assays for MAP infection and JD in farmed deer. An
inhouse qPCR assay for faecal shedding was firstly vali-
dated using proficiency panels consisting of bovine faecal
samples of previously determined MAP titre and subse-
quently applied to a panel of 663 cervine faecal samples
for which matched blood samples were available.
Results
Validation of qPCR and Correlation of qPCR with culture
techniques
In order to evaluate the precision of an inhouse faecal
qPCR of cervine samples against conventional culture-
based MAP quantification methodologies a proficiency
panel of bovine faecal samples of known infection status
and faecal culture titre, administered through the US
National Veterinary Services Laboratory (NVSL), Ames,
Iowa as part of an ongoing JD proficiency testing panelfor diagnostic laboratories was used [31]. The NVSL JD
Proficiency Panels are distributed annually to diagnostic
and research laboratories in the US and internationally
and are used to accredit testing services for JD diagnos-
tic testing in the US. Each panel consists of 26 blinded-
duplicate (bovine) faecal samples, with one sample
identified as a positive control, and includes designated
critical-pass positive and negative samples along with
samples spiked with mycobacterial species other than
MAP. Positive samples were collected from naturally
infected cows and negative samples from individual cattle
in non-infected herds. Faecal samples comprising cumula-
tive proficiency panels from 2008 – 2010 were assessed
(n = 78). The qPCR assay identified 26/26 (100%) of the
isolates correctly from the 2008 panel, which included one
sample spiked with M. avium, which was correctly identi-
fied as MAP negative. Using the 2009 panel one of the du-
plicates for animal 19, a very low shedder, was misclassified
as negative by qPCR when solid culture had returned a re-
sult of 2 CFU/tube although the duplicate sample from this
animal was correctly identified. Overall for the 2009 panel,
24/25 (96%) of the isolates were correctly identified. The
2009 panel also included one sample spiked with M.
fortuitum which was correctly identified as MAP negative.
The 2010 proficiency panel included four low shedding
samples which were not included for official grading pur-
poses by the panel administrators as shedding levels were
so low that <70% were identified as positive by participat-
ing laboratories, leaving 21 valid samples; of these, 21/21
(100%) were correctly identified. The retrospective assess-
ment of the’08,’09 and’10 NVSL panels indicated that qPCR
correctly identified 72/73 (99%) of the valid diagnostic
specimens. The observed correlation in organism quantita-
tion between faecal qPCR and MAP culture on HEY solid
medium (Spearman r = 0.9325; p <0.0001) based on the
NVSL JD Proficiency Panels is illustrated in Figure 1 and
the combined results for the three proficiency panels are
reported in Additional file 1: Table S1; these data con-
firmed that the inhouse qPCR methodology utilised for
quantitation of MAP in cervine faeces was returning
meaningful results. While the qPCR validation results were
based on bovine faecal samples, no significant differences
in the analysis of cervine faeces were anticipated. The pro-
ficiency panel dataset also allowed sensitivity and specificity
values to be calculated for the qPCR assay at different
shedding thresholds taking culture on HEY solid medium
as a gold standard; these data are presented in Table 1.
Correlation between qPCR and Histopathological Severity
Score
A recently described histopathological severity scoring
system for the objective description of JD pathology in
deer [4] was used to compare active disease as defined by
histopathology scores to faecal shedding as determined by
Figure 1 Correlation between MAP titre as determined by qPCR
and faecal culture on HEYM. Correlation of faecal qPCR data
against HEYM solid culture based on cumulative NVSL JD Proficiency
Panel Samples for 2008, 2009 and 2010; n = 72 (of a total of 78
individual faecal samples, two did not have associated colony
counts and four were disregarded for official grading purposes).
Spearman Correlation = 0.9325; p <0.0001.
O’Brien et al. BMC Veterinary Research 2013, 9:72 Page 4 of 9
http://www.biomedcentral.com/1746-6148/9/72qPCR. This scoring system ranks JD histopathological
severity on a numerical scale from 0 (normal histology
with no lesions or acid-fast organisms visible) through low
to moderate grade tissue damage (with increasing score
values reflecting increasing numbers of granulomas, sub-
mucosal lesions and bluntening of villi) up to a maximum
score of 13 (encompassing large areas of granulomatous
lesions (including caseated calcified lesions) in intestine or
lymph node, submucosal lesions, marked bluntening of
villi and granulomas in lymph node capsule and/or ser-
osa/mesentery). Examination of a small dataset of samples
(n = 40) for which matched histopathological severity sco-
ring and faecal qPCR data were both available, revealed a
significant correlation (Spearman r = 0.7345; p <0.0001),
with higher levels of shedding associated with samples
obtained from animals with the most severe histopatho-
logical lesion severity scores and reduced shedding in
samples of lesser disease severity (Figure 2). Within this
small dataset there were two samples with histological se-
verity scores of 0 which estimated faecal shedding of >103Table 1 Sensitivity and specificity values for qPCR
calculated using HEYM culture as a gold standard
Shedding threshold for qPCR test positivity (organisms/g)
10-1 101 102 103 104 105 106
Sens. 0.91 0.91 0.91 0.85 0.68 0.52 0.37
Spec. 0.73 0.73 0.83 0.89 1.00 1.00 1.00
PPV 0.91 0.91 0.94 0.95 1.00 1.00 1.00
NPV 0.74 0.74 0.75 0.66 0.52 0.42 0.35
Sensitivity and specificity values for qPCR calculated for different shedding
states using HEY solid medium as a gold standard based on NVSL proficiency
panel culture results.and >105 organisms/g respectively, which may be due to
sampling error limitations associated with tissue sampling.
However, of the 28/40 samples which recorded the ma-
ximum histopathological severity score of 13, 26/28 (93%)
were determined to be shedding >106 organisms/g. These
data suggest that significant faecal shedding of MAP is a
reasonable indicator of clinical JD as determined by histo-
pathological analysis.
Correlation of qPCR with ELISA using cervine samples
While MAP qPCR and the Paralisa™ (ELISA) assay dis-
tinct biological parameters (organism enumeration vs.
immunological response), it seemed reasonable to as-
sume that MAP shedding would correlate with disease
severity and also serological reactivity. As the disease
state cannot be quantified in ante-mortem samples, we
examined matched data from 663 cervine blood samples
submitted for routine JD testing by Paralisa™ (PPD-J)
for which faecal samples had also been obtained and
submitted at the time of blood sampling. The correlation
between qPCR and ELISA was not as strong as that ob-
served for qPCR and culture, although a significant cor-
relation (Spearman r = 0.4325; p <0.0001) was observed,
suggesting that with strongly positive Paralisa™ results,
there was a greater chance that the animal was shedding
high numbers of organisms in its faeces. Conversely,
low antibody reactivity corresponded with lower inci-
dence of MAP faecal shedding. These data are illus-
trated in Figure 3.
In light of the fact that neither ELISA nor qPCR pro-
vide binary (positive/negative) but rather scalar data and
rely on cutpoints to be assigned to differentiate positive
from negative samples, any value for sensitivity or speci-
ficity for these tests becomes cutpoint dependant. ByFigure 2 Correlation between MAP titre as determined by qPCR
and Histopathological Lesion Severity Score. Correlation of faecal
MAP titre as determined by qPCR and Histopathological Lesion
Severity Score; n = 40, Spearman Correlation r = −0.7345; p <0.0001.
Figure 3 Correlation between ELISA reactivity and MAP titre as determined by qPCR. Panel A; Correlation of faecal MAP titre as
enumerated by qPCR vs ELISA (Paralisa™) reactivity of matched cervine blood samples (Johnin antigen); Spearman correlation r = 0.4325;
p <0.0001. Panel B; Correlation of faecal MAP titre as enumerated by qPCR vs ELISA (Paralisa™) reactivity of matched blood samples
(Protoplasmic antigen); Spearman correlation r = 0.4006; p < 0.0001. n = 663. Red circle = Overall Paralisa™ result = positive; Light green circle =
Overall Paralisa™ result = negative.
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was possible to calculate values for sensitivity, specificity
and for positive and negative predictive values for sero-
logical reactivity for a range of positive outcomes and for
a range of shedding states (Table 2). In this dataset the
negative predictive value of Paralisa™ for moderate bacter-
ial shedding (>104 organisms/g was 0.90. With higher
levels of faecal shedding (≥106 organisms/g) the NPV rose
to 0.97 and at the highest shedding levels detected (≥108
organisms/g) NPV was 1.00. Few (16/663; 2.4%) Paralisa™negative animals (PPD-J; <50EU) were found to shed
moderate or high (>105 organisms/g) numbers of MAP in
their faeces. By contrast, the positive predictive value
(PPV) of Paralisa™ for faecal shedding (≥104 organisms/g)
was 0.55, suggesting that a Paralisa™ positive result with
a cutoff value for positivity of ≥50EU is not strongly
predictive for shedding. At ≥150EU, however, PPV for
Paralisa™ rose to 0.88 with a corresponding NPV of
0.85. In a recent review of JD in cattle and other suscep-
tible species Sweeney et al. (2012) urged clinicians not
Table 2 Sensitivity and specificity values for Paralisa™ calculated using faecal qPCR as a gold standard
Shedding Threshold for Positivity (organisms/g)
≥102 ≥103 ≥104 ≥105 ≥106 ≥107 ≥108
Paralisa Overall Sens. 0.62 0.67 0.78 0.87 0.89 0.96 0.98
Spec. 0.70 0.68 0.63 0.62 0.61 0.60 0.58
PPV 0.70 0.61 0.41 0.35 0.31 0.26 0.20
NPV 0.62 0.74 0.90 0.95 0.97 0.99 1.00
PPD-J EU >50 Sens. 0.46 0.52 0.70 0.82 0.84 0.91 0.94
Spec. 0.85 0.84 0.81 0.81 0.79 0.78 0.75
PPV 0.78 0.71 0.55 0.50 0.44 0.37 0.28
NPV 0.58 0.70 0.89 0.95 0.96 0.98 0.99
PPD-J EU >100 Sens. 0.34 0.40 0.62 0.74 0.78 0.86 0.89
Spec. 0.94 0.93 0.93 0.92 0.91 0.89 0.86
PPV 0.87 0.82 0.73 0.67 0.62 0.53 0.40
NPV 0.55 0.68 0.88 0.94 0.95 0.98 0.99
PPD-J EU >150 Sens. 0.24 0.29 0.48 0.60 0.64 0.75 0.81
Spec. 0.98 0.98 0.98 0.97 0.96 0.96 0.93
PPV 0.93 0.92 0.88 0.83 0.78 0.71 0.56
NPV 0.53 0.65 0.85 0.91 0.93 0.96 0.98
Sensitivity (Sens.), specificity (Spec.), positive and negative predictive values (PPV and NPV, respectively) for ParalisaTM to predict MAP shedding in deer as
determined by qPCR. ‘Paralisa Overall’ indicates the final result when Johnin and Protoplasmic Antigen responses are interpreted in parallel; EU, ELISA Units.
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results but rather to interpret quantitative results
(ELISA Optical density (OD) or Standard/Positive (S/P)
ratio) which correlate well with the likelihood of (and
degree of ) faecal shedding of MAP [32,33]; this view-
point would appear to be strongly supported when con-
sidering test results in deer also.
Instances where Paralisa™ positive samples exhibited
low or no shedding in matched faecal samples may be
explained through intermittency of shedding, sampling
error or the stage of the MAP infection cycle at which
samples were tested, particularly in subclinical individ-
uals. When considering the data provided in Table 2,
however, it should be noted that these data do not pro-
vide a true estimate of test specificity, as most of the
data was derived from herds where MAP infection was
present; a more accurate estimate of test specificity would
become evident if the dataset for specificity estimates were
derived using herds free from MAP infection.
Discussion
Diagnosis of JD in the live animal is challenging and the
prompt identification of animals shedding significant
numbers of MAP bacilli would be a valuable management
tool. Earlier published data [3] showed an estimated sensi-
tivity of 0.77 for a customized ELISA (Paralisa™) test to
diagnose MAP infection in deer. While this test has been
used successfully to control infection in a test and cull
programme [15] there was concern that this approach
could result in wastage of valuable stud stock as falsepositive reactors. The current study provides evidence that
faecal qPCR could be used as a sequential ancillary to the
Paralisa™. Because qPCR is comparatively labour intensive
and expensive it is not practical for use on individual ani-
mals as a whole herd screening test and it has been used
as a research tool rather than as a frontline diagnostic test
in NZ. The selective use of faecal qPCR as a sequential an-
cillary test for whole herd tested ELISA positive animals
either as individual or pooled tests, brings such testing
into the realm of practicable application.
Considering the ubiquitous nature of MAP within
infected herds the intended purpose of the faecal qPCR
test was not to diagnose the presence of MAP per se,
but rather to diagnose animals shedding a minimal
threshold of bacilli to justify selective culling, or to con-
firm the JD status in high-value animals using ancillary
testing. The value of faecal qPCR testing relates to the
speed with which it can identify infectious or affected
high shedder animals that pose a risk for environmental
spread of infection. As qPCR becomes increasingly ac-
cepted and adopted as a routine JD diagnostic method-
ology, it will become necessary to determine what level
of MAP shedding may be indicative of passive transfer
of MAP arising from a contaminated environment as
opposed to an infectious, affected or diseased state. The
detection of very low/trace numbers of MAP organisms
in ruminant faeces may not be informative or useful
until we have a clear understanding as to what may con-
stitute normal bacterial shedding or pass-through of an
environmental contaminant through the intestine of a
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the test parameters used must be dictated by the pur-
pose for which the test is applied whether it be whole
herd screening, testing of replacements prior to bringing
animals onto a property or selection of animals for
culling. The prevalence of MAP infection and degree of
environmental contamination must also be taken into ac-
count and no single set of parameters will satisfy universal
requirements. Nonetheless, tests that can efficiently detect
animals shedding high numbers in their faeces are vital
for an effective JD management programme and the early
identification and prompt removal of such shedders is
generally accepted as essential.
While we do not yet understand what level of shed-
ding may mark a transition from exposure through to
subclinical infection and development of clinical disease,
longitudinal testing of larger number of animals using
sequential diagnostic tests will identify threshold values
that correlate with these states. While it is known that
faecal shedding of MAP in deer can be intermittent, es-
pecially in subclinical individuals, it is likely that signifi-
cantly affected animals will remain as persistent and
consistent high level shedders. While terminal JD results
in scouring and wastage of affected deer, a significant
proportion of high shedding animals may show no evi-
dence of scouring, indeed some of the highest MAP ti-
tres detected as part of this study were recovered from
well formed, solid faecal pellets as opposed to liquefied
faeces. It has similarly been reported that cattle showing
no clinical signs of JD or scouring may be capable of
shedding >106 CFU of MAP per gram of faeces [24].
Polymerase Chain Reaction based tests offer potential
for continued development, particularly in regard to
sample preparation, to further improve upon sensitivity,
automation, throughput and to achieve improved
cost-effectiveness. In particular there is scope for semi-
automation of DNA extraction through the use of
improving extraction technologies incorporating laboratory
robotics; the setup and execution of the PCR itself is simi-
larly amenable to automation. The development of improved
PCR is ongoing in research laboratories internationally
and increasing numbers of commercial suppliers are de-
veloping PCR tests for MAP in kit form, all of which will
continue to advance PCR as a valid alternative to conven-
tional culture methodologies. Culture based approaches,
by comparison, are less likely to be significantly improved
upon due to the inherent limitation resulting from the
slow growth rate of this organism in culture and difficul-
ties associated with its early detection and quantitation.
Conclusions
Data obtained with qPCR compares favourably with cul-
ture in terms of sensitivity, cost and speed but will re-
main more expensive than ELISA for MAP diagnosis.While MAP culture is more sensitive in detecting ani-
mals shedding few MAP organisms, it is questionable
whether sensitivity and precision to distinguish the pres-
ence of MAP (the organism) or a host affected by JD is
most relevant. The results reported here suggest that a
rapid qPCR assay for MAP in deer faeces could provide
another tool in the JD management toolkit. Current data
on qPCR in farmed deer, used in sequence with
Paralisa™ could become a practical strategy to identify
and cull animals shedding significant numbers of MAP.
Use of this technology could limit the spread of MAP in-
fection, minimise production/reproduction losses from




The methodology outlined in this paper was based on
previously published parameters for ELISA immunoas-
says (Paralisa™) used to diagnose immune reactions in
deer to MAP infection [3]. This serological test quanti-
fies antibody responses to two distinct protein antigens
in parallel, a denatured antigen in the form of Purified
Protein Derivative – Johnin (PPD-J) and a native protein
in the form of Protoplasmic Antigen (PPA); final test re-
sults are arrived at by considering both test antigens in
parallel. Deer disease severity was based on histopath-
ology severity scores, using necropsy specimens obtained
from natural and experimental infection studies in deer
involving virulent MAP [4].
qPCR
Levels of MAP shedding in cervine faecal samples were
determined using an inhouse qPCR assay. Descriptions
of a number of qPCR based assays for quantitation of
MAP have appeared in the literature in recent years and
quantitation of MAP bacilli in faecal material using
qPCR, competently employed, is now considered routine
and to be on a par with faecal culture in terms of diagnos-
tic performance [32,34]. In brief, the current qPCR assay
utilised F57, a single-copy, species-specific sequence diag-
nostic target [35,36], using hydrolysis probe based chemis-
try. Every assay included an internal amplification control
molecule labelled with a second reporter dye co-amplified
alongside the diagnostic target in a duplex format to ex-
clude false negative reactions and to disclose any inhibition
of the reaction; appropriate biological and technical repli-
cates and necessary positive and negative controls were
also included. Quantitation of MAP titre was accomplished
by preparing a standard curve using serial log dilutions of
MAP bacilli. DNA from cervine faecal samples (3g) was
homogenised and total DNA extracted and purified using
a combination of physical and chemical methods; final
cleanup and removal of any coextracted inhibitors was
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(Zymo Research Corp., CA, USA). Both diagnostic target
and internal control amplification assays each displayed
amplification efficiencies of 100%.
Additional file
Additional file 1: Table S1. Validation of faecal qPCR against
cumulative USDA proficiency panels from 2008 – 2010.
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